FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1569134566> ?p ?o ?g. }

• W1569134566 endingPage "1812" @default.
• W1569134566 startingPage "1803" @default.
• W1569134566 abstract "Background: Relatively few studies have examined gender differences in the effectiveness of specific behavioral or pharmacologic treatment of alcohol dependence. The aim of this study is to assess whether there were gender differences in treatment outcomes for specific behavioral and medication treatments singly or in combination by conducting a secondary analysis of public access data from the national, multisite NIAAA-sponsored COMBINE study. Methods: The COMBINE study investigated alcohol treatment among 8 groups of patients (378 women, 848 men) who received medical management (MM) with 16 weeks of placebo, naltrexone (100 mg/day), acamprosate (3 g/day), or their combination with or without a specialist-delivered combined behavioral intervention. We examined efficacy measures separately for men and women, followed by an overall analysis that included gender and its interaction with treatment condition in the analyses. These analyses were performed to confirm whether the findings reported in the parent trial were also relevant to women, and to more closely examine secondary outcome variables that were not analyzed previously for gender effects. Results: Compared to men, women reported a later age of onset of alcohol dependence by approximately 3 years, were significantly less likely to have had previous alcohol treatment, and drank fewer drinks per drinking day. Otherwise, there were no baseline gender differences in drinking measures. Outcome analyses of 2 primary (percent days abstinent and time to first heavy drinking day) and 2 secondary (good clinical response and percent heavy drinking days) drinking measures yielded the same overall pattern in each gender as that observed in the parent COMBINE study report. That is, only the naltrexone by behavioral intervention interaction reached or approached significance in women as well as in men. There was a naltrexone main effect that was significant in both men and women in reduction in alcohol craving scores with naltrexone-treated subjects reporting lower craving than placebo-treated subjects. Conclusions: This gender-focused analysis found that alcohol-dependent women responded to naltrexone with COMBINE’s Medical Management, similar to the alcohol-dependent men, on a wide range of outcome measures. These results suggest that clinicians can feel comfortable prescribing naltrexone for alcohol dependence in both men and women. In this study, it is also notable that fewer women than men reported receiving any alcohol treatment prior to entry into the COMBINE study. Of note, women tend to go to primary health care more frequently than to specialty substance abuse programs for treatment, and so the benefit we confirm for women of the naltrexone and MM combination has practical implications for treating alcohol-dependent women." @default.
• W1569134566 created "2016-06-24" @default.
• W1569134566 creator A5008749381 @default.
• W1569134566 creator A5012569208 @default.
• W1569134566 creator A5016763533 @default.
• W1569134566 creator A5056190046 @default.
• W1569134566 creator A5065273954 @default.
• W1569134566 date "2010-07-20" @default.
• W1569134566 modified "2023-10-17" @default.
• W1569134566 title "Gender Differences in Alcohol Treatment: An Analysis of Outcome From the COMBINE Study" @default.
• W1569134566 cites W1475474724 @default.
• W1569134566 cites W1970343218 @default.
• W1569134566 cites W1974604729 @default.
• W1569134566 cites W1977914858 @default.
• W1569134566 cites W1981814552 @default.
• W1569134566 cites W1982695631 @default.
• W1569134566 cites W1998138099 @default.
• W1569134566 cites W2000963245 @default.
• W1569134566 cites W2001436696 @default.
• W1569134566 cites W2002869525 @default.
• W1569134566 cites W2014344383 @default.
• W1569134566 cites W2020940577 @default.
• W1569134566 cites W2031298781 @default.
• W1569134566 cites W2034261778 @default.
• W1569134566 cites W2042735290 @default.
• W1569134566 cites W2045141721 @default.
• W1569134566 cites W2046700062 @default.
• W1569134566 cites W2049032077 @default.
• W1569134566 cites W2057636159 @default.
• W1569134566 cites W2063044913 @default.
• W1569134566 cites W2063972263 @default.
• W1569134566 cites W2084450389 @default.
• W1569134566 cites W2086865407 @default.
• W1569134566 cites W2090169982 @default.
• W1569134566 cites W2101372918 @default.
• W1569134566 cites W2102646887 @default.
• W1569134566 cites W2112460193 @default.
• W1569134566 cites W2123282949 @default.
• W1569134566 cites W2124650677 @default.
• W1569134566 cites W2124669459 @default.
• W1569134566 cites W2136699557 @default.
• W1569134566 cites W2159950826 @default.
• W1569134566 cites W2361945527 @default.
• W1569134566 cites W2955761657 @default.
• W1569134566 cites W4237161941 @default.
• W1569134566 cites W2097572230 @default.
• W1569134566 doi "https://doi.org/10.1111/j.1530-0277.2010.01267.x" @default.
• W1569134566 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3048309" @default.
• W1569134566 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20645934" @default.
• W1569134566 hasPublicationYear "2010" @default.
• W1569134566 type Work @default.
• W1569134566 sameAs 1569134566 @default.
• W1569134566 citedByCount "80" @default.
• W1569134566 countsByYear W15691345662012 @default.
• W1569134566 countsByYear W15691345662013 @default.
• W1569134566 countsByYear W15691345662014 @default.
• W1569134566 countsByYear W15691345662015 @default.
• W1569134566 countsByYear W15691345662016 @default.
• W1569134566 countsByYear W15691345662017 @default.
• W1569134566 countsByYear W15691345662018 @default.
• W1569134566 countsByYear W15691345662019 @default.
• W1569134566 countsByYear W15691345662020 @default.
• W1569134566 countsByYear W15691345662021 @default.
• W1569134566 countsByYear W15691345662022 @default.
• W1569134566 countsByYear W15691345662023 @default.
• W1569134566 crossrefType "journal-article" @default.
• W1569134566 hasAuthorship W1569134566A5008749381 @default.
• W1569134566 hasAuthorship W1569134566A5012569208 @default.
• W1569134566 hasAuthorship W1569134566A5016763533 @default.
• W1569134566 hasAuthorship W1569134566A5056190046 @default.
• W1569134566 hasAuthorship W1569134566A5065273954 @default.
• W1569134566 hasBestOaLocation W15691345662 @default.
• W1569134566 hasConcept C118552586 @default.
• W1569134566 hasConcept C126322002 @default.
• W1569134566 hasConcept C142724271 @default.
• W1569134566 hasConcept C170493617 @default.
• W1569134566 hasConcept C185592680 @default.
• W1569134566 hasConcept C190385971 @default.
• W1569134566 hasConcept C204787440 @default.
• W1569134566 hasConcept C27081682 @default.
• W1569134566 hasConcept C2777972943 @default.
• W1569134566 hasConcept C2779442783 @default.
• W1569134566 hasConcept C2779992327 @default.
• W1569134566 hasConcept C2781063702 @default.
• W1569134566 hasConcept C2781066024 @default.
• W1569134566 hasConcept C3017483375 @default.
• W1569134566 hasConcept C3017944768 @default.
• W1569134566 hasConcept C55493867 @default.
• W1569134566 hasConcept C70410870 @default.
• W1569134566 hasConcept C71924100 @default.
• W1569134566 hasConcept C99454951 @default.
• W1569134566 hasConceptScore W1569134566C118552586 @default.
• W1569134566 hasConceptScore W1569134566C126322002 @default.
• W1569134566 hasConceptScore W1569134566C142724271 @default.
• W1569134566 hasConceptScore W1569134566C170493617 @default.
• W1569134566 hasConceptScore W1569134566C185592680 @default.
• W1569134566 hasConceptScore W1569134566C190385971 @default.
• W1569134566 hasConceptScore W1569134566C204787440 @default.

• next